SANCUSO benefits you and your patients

Easy to use

The SANCUSO patch is easy to apply; similar to
applying a BAND-AID^® to the arm
Reduces the need for additional staff or medical supplies
Reduces the need to write additional 5-HT₃ prescriptions
to cover delayed CINV
The SANCUSO patch is 52 cm² or approx. 2.5 in x 3 in

Offers flexibility

You can apply SANCUSO in the office
Patient can apply SANCUSO at home — reducing unnecessary trips back to the office

Patient compliance

For most patients, SANCUSO adheres well and remains in place throughout the course of treatment
Medication delivered continuously for 5 days so compliance is not an issue
May avoid the unnecessary visits for breakthrough CINV complications, such as dehydration

BAND-AID is a registered trademark of Johnson & Johnson.

IMPORTANT SAFETY INFORMATION
SANCUSO^® (Granisetron Transdermal System) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.¹ SANCUSO is contraindicated in patients with known hypersensitivity to granisetron or to any of the components of the patch.¹ Granisetron may mask a progressive ileus and/or gastric distention caused by the underlying condition.¹ Mild application site reactions have occurred; remove the patch if severe reaction or a generalized skin reaction occurs.¹ Patients should avoid direct exposure of application site to natural or artificial sunlight by covering with clothing while wearing the patch and for 10 days after removing it.¹ The most common adverse reaction in patients receiving SANCUSO is constipation (5.4%).¹ SANCUSO contains granisetron.¹ Healthcare professionals should avoid prescribing any additional products that contain granisetron. No clinically relevant drug interactions have been reported in clinical studies with SANCUSO.¹